FDA — authorised 17 March 1978
- Marketing authorisation holder: RANBAXY
- Status: approved
🇺🇸 Westcort in United States
FDA authorised Westcort on 17 March 1978
Marketing authorisations
FDA — authorised 17 March 1978
- Application: NDA017950
- Marketing authorisation holder: SUN PHARM INDS INC
- Local brand name: WESTCORT
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 8 August 1983
- Application: NDA018726
- Marketing authorisation holder: SUN PHARM INDS INC
- Local brand name: WESTCORT
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 25 August 1998
- Application: ANDA075042
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 25 August 1998
- Application: ANDA075043
- Marketing authorisation holder: SUN PHARMA CANADA
- Local brand name: HYDROCORTISONE VALERATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 24 May 2000
- Application: ANDA075666
- Marketing authorisation holder: PADAGIS ISRAEL
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 31 July 2001
- Application: ANDA075085
- Marketing authorisation holder: FOUGERA PHARMS
- Local brand name: HYDROCORTISONE VALERATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 12 October 2018
- Application: ANDA211129
- Marketing authorisation holder: GLENMARK PHARMS LTD
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 14 December 2018
- Application: ANDA211750
- Marketing authorisation holder: GLENMARK PHARMS LTD
- Local brand name: HYDROCORTISONE VALERATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 15 August 2019
- Application: ANDA210307
- Marketing authorisation holder: LUPIN
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 4 March 2020
- Application: ANDA211764
- Marketing authorisation holder: COSETTE
- Local brand name: HYDROCORTISONE VALERATE
- Indication: OINTMENT — TOPICAL
- Status: approved
FDA — authorised 11 February 2021
- Application: ANDA213724
- Marketing authorisation holder: COSETTE
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
FDA — authorised 4 November 2021
- Application: ANDA211047
- Marketing authorisation holder: ENCUBE ETHICALS
- Local brand name: HYDROCORTISONE VALERATE
- Indication: CREAM — TOPICAL
- Status: approved
Westcort in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in United States
Frequently asked questions
Is Westcort approved in United States?
Yes. FDA authorised it on 17 March 1978; FDA authorised it on 17 March 1978; FDA authorised it on 8 August 1983.
Who is the marketing authorisation holder for Westcort in United States?
RANBAXY holds the US marketing authorisation.